Telehealth Stock Could Rebound Off Long-Term Trendline

Core Insights - HIMS stock is currently trading at $47.82, showing a 0.8% increase, and is positioned near a long-term trendline with historically bullish implications [1] - Despite a recent pullback due to comments from President Trump regarding Novo Nordisk's products, HIMS is still up 98.9% year-to-date, with support at the $40 level [2] - Historical data indicates that similar signals have led to a 78% chance of the stock rising one week later, averaging a 6.3% increase, which could push HIMS above $51 [4] - HIMS has a strong history of exceeding options traders' volatility expectations, reflected in its Schaeffer's Volatility Scorecard (SVS) rating of 83 out of 100 [5]